Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | AdV-tk |
| Trade Name | |
| Synonyms | Aglatimagene besadenovec|GliAtak|ProstAtak|CAN-2409|CAN2409|Virafir |
| Drug Descriptions |
ADV-tk (aglatimagene besadenovec) is an engineered adenoviral vector expressing the herpes simplex virus thymidine kinase that sensitizes tumor cells to therapy with acyclic guanosine analogues (PMID: 26843484, PMID: 30883662). |
| DrugClasses | |
| CAS Registry Number | 1621271-62-2 |
| NCIT ID | C73996 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Acyclovir + AdV-tk | Acyclovir AdV-tk | 0 | 1 |
| AdV-tk | AdV-tk | 0 | 2 |
| AdV-tk + Nivolumab | AdV-tk Nivolumab | 0 | 1 |
| AdV-tk + Valacyclovir | AdV-tk Valacyclovir | 0 | 6 |